Kezar Life Sciences to Present at H.C. Wainwright Virtual BioConnect Conference

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq:KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced its Chief Executive Officer, John Fowler, will present a corporate overview at the H.C. Wainwright Virtual BioConnect Conference, being held on January 11-14, 2021. The presentation will be available on Monday, January 11, 2021 at 6:00am EST and may be accessed

Click to view original post